SCHEMBL6487290

SCHEMBL6487290

C[Si](C)(C)CCOC(=O)CCC(=O)c1c[nH]c2ccc(Br)cc12

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.51
GABRA1 P14867 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRA3 P34903 1/20 0.48
GABRB2 P47870 1/20 0.48
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
LMNA P02545 3/20 0.42
MEN1 O00255 2/20 0.42
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
RAB9A P51151 2/20 0.41
MITF O75030 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PYGL P06737 1/20 0.40
CTNNB1 P35222 1/20 0.40
WNT3A P56704 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5063303 0.87 PYGL (0.56) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL5225716 0.82 NR4A2 (0.67) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL5067961 0.77 ADAM17 (0.64) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL15636289 0.74 NR4A2 (0.70) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL25305901 0.74 NR4A2 (0.64) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL30457500 0.74 NR4A2 (0.64) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL1612772 0.72 LMNA (0.68) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL1613529 0.71 NR4A2 (0.60) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL5739049 0.71 GABRA1 (0.82) NR4A2GABRA1GABRB1GABRA3GABRB2
SCHEMBL3130989 0.70 NR4A2 (0.52) NR4A2GABRA1GABRB2MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009817-A1 Substituted heteroaryls INSTITUTES FOR PHARMACEUTICAL DISCOVERY, L.L.C. 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009817-A1 Substituted heteroaryls PTPRS, PTPRO, PTPRR NR4A2 4086/4885GABRA1 2797/4885GABRB1 1275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.